Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 566

1.

Building more accurate decision trees with the additive tree.

Luna JM, Gennatas ED, Ungar LH, Eaton E, Diffenderfer ES, Jensen ST, Simone CB 2nd, Friedman JH, Solberg TD, Valdes G.

Proc Natl Acad Sci U S A. 2019 Sep 16. pii: 201816748. doi: 10.1073/pnas.1816748116. [Epub ahead of print]

2.

Physician overextenders.

Friedman JH.

R I Med J (2013). 2019 Sep 3;102(7):11-12. No abstract available.

PMID:
31480810
3.

Tardive Syndromes.

Friedman JH.

Continuum (Minneap Minn). 2019 Aug;25(4):1081-1098. doi: 10.1212/CON.0000000000000754.

PMID:
31356294
4.

Recent developments in drug-induced movement disorders: a mixed picture.

Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL.

Lancet Neurol. 2019 Sep;18(9):880-890. doi: 10.1016/S1474-4422(19)30152-8. Epub 2019 Jul 3. Review.

PMID:
31279747
5.

Early- vs late-start levodopa relieved symptoms but did not affect disease progression in Parkinson disease.

Friedman JH.

Ann Intern Med. 2019 May 21;170(10):JC56. doi: 10.7326/ACPJ201905210-056. No abstract available.

PMID:
31108518
6.

Commentary on "The Neuropsychiatry of Parkinson's Disease: A Perfect Storm".

Friedman JH.

Am J Geriatr Psychiatry. 2019 Sep;27(9):1019-1021. doi: 10.1016/j.jagp.2019.03.007. Epub 2019 Mar 20. No abstract available.

PMID:
30987802
7.

Response to Point of View on the Question of Bias.

Friedman JH.

R I Med J (2013). 2019 Apr 1;102(3):13. No abstract available.

PMID:
30943665
8.

Response to Letter to the Editor.

Friedman JH, D'Abreu A.

Tremor Other Hyperkinet Mov (N Y). 2019 Feb 6;9:630. doi: 10.7916/0rjw-cv10. eCollection 2019.

9.

'Goodbye, and thanks…'.

Friedman JH.

R I Med J (2013). 2018 Dec 3;101(10):8-9. No abstract available.

PMID:
30508999
10.

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.

Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D.

Mov Disord. 2018 Nov;33(11):1769-1776. doi: 10.1002/mds.27488. Epub 2018 Nov 2.

11.

What to do when bad news isn't understood?

Friedman JH.

R I Med J (2013). 2018 Nov 1;101(9):7-8. No abstract available.

PMID:
30384511
12.

SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response.

Faber I, Martinez ARM, Martins CR Jr, Maia ML, Souza JP, Lourenço CM, Marques W Jr, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Ramos CD, Lopes-Cendes Í, Friedman JH, Amorim BJ, França MC Jr.

Mov Disord. 2018 Oct;33(10):1650-1656. doi: 10.1002/mds.27491. Epub 2018 Oct 10.

PMID:
30306626
13.

The why of neurological reflexes.

Friedman JH.

R I Med J (2013). 2018 Oct 1;101(8):8-9. No abstract available.

PMID:
30278592
14.

Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review.

D'Abreu A, Friedman JH.

Tremor Other Hyperkinet Mov (N Y). 2018 Aug 31;8:570. doi: 10.7916/D8FF58Z9. eCollection 2018. Review.

15.

Sotto voce.

Friedman JH.

R I Med J (2013). 2018 Sep 4;101(7):7. No abstract available.

PMID:
30189696
16.

A novel promising therapeutic approach for patients with ataxic disorders?

Fujioka S, Tsuboi Y, Friedman JH.

Neurology. 2018 Sep 18;91(12):541-542. doi: 10.1212/WNL.0000000000006190. Epub 2018 Aug 22. No abstract available.

PMID:
30135252
17.

Motor asymmetry over time in Parkinson's disease.

Miller-Patterson C, Buesa R, McLaughlin N, Jones R, Akbar U, Friedman JH.

J Neurol Sci. 2018 Oct 15;393:14-17. doi: 10.1016/j.jns.2018.08.001. Epub 2018 Aug 3.

PMID:
30096567
18.

Apathy.

Friedman JH.

R I Med J (2013). 2018 Aug 1;101(6):9-10. No abstract available.

PMID:
30068044
19.

Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review.

Friedman JH.

Clin Neuropharmacol. 2018 Sep/Oct;41(5):156-159. doi: 10.1097/WNF.0000000000000296.

PMID:
30004964
20.

Inflammation and fatigue in early, untreated Parkinson's Disease.

Herlofson K, Heijnen CJ, Lange J, Alves G, Tysnes OB, Friedman JH, Fagundes CP.

Acta Neurol Scand. 2018 Nov;138(5):394-399. doi: 10.1111/ane.12977. Epub 2018 Jun 26.

PMID:
29947088
21.

Evidence-based Medicine.

Friedman JH.

R I Med J (2013). 2018 Jun 1;101(5):8-9. No abstract available.

PMID:
29857596
22.

Analogies.

Friedman JH.

R I Med J (2013). 2018 May 1;101(4):7-8. No abstract available.

PMID:
29703069
23.

Quetiapine for Parkinson's Disease psychosis: Evidence-based medicine versus expert belief: A case study.

Friedman JH.

Mov Disord. 2018 Jul;33(7):1186-1187. doi: 10.1002/mds.27378. Epub 2018 Apr 11. No abstract available.

PMID:
29644756
24.

Thinking too much is bad for some brains.

Friedman JH.

R I Med J (2013). 2018 Apr 2;101(3):7-8. No abstract available.

PMID:
29608625
25.

Pharmacological interventions for psychosis in Parkinson's disease patients.

Friedman JH.

Expert Opin Pharmacother. 2018 Apr;19(5):499-505. doi: 10.1080/14656566.2018.1445721. Epub 2018 Mar 1. Review.

PMID:
29494265
26.

Expert opinions.

Friedman JH.

R I Med J (2013). 2018 Mar 1;101(2):8-9. No abstract available.

PMID:
29490314
27.

Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.

Bhidayasiri R, Jitkritsadakul O, Friedman JH, Fahn S.

J Neurol Sci. 2018 Jun 15;389:67-75. doi: 10.1016/j.jns.2018.02.010. Epub 2018 Feb 5.

PMID:
29454493
28.

Tardive dyskinesia: Epidemiology.

D'Abreu A, Akbar U, Friedman JH.

J Neurol Sci. 2018 Jun 15;389:17-20. doi: 10.1016/j.jns.2018.02.007. Epub 2018 Feb 5. Review.

PMID:
29433811
29.

MCI in Parkinson's disease.

Friedman JH.

Parkinsonism Relat Disord. 2018 Feb;47:1-2. doi: 10.1016/j.parkreldis.2018.01.015. No abstract available.

PMID:
29413123
30.

Reflections from the editor-in-chief on 20-year tenure.

Friedman JH.

R I Med J (2013). 2018 Feb 2;101(1):7-8.

PMID:
29393301
31.

When the doctor is crazier than the patient.

Friedman JH.

R I Med J (2013). 2017 Dec 1;100(12):8-9.

PMID:
29190835
32.

Enteric Pathologic Manifestations of Alpha-Synucleinopathies.

Punsoni M, Friedman JH, Resnick M, Donahue JE, Yang DF, Stopa EG.

Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):543-548. doi: 10.1097/PAI.0000000000000613.

PMID:
29189256
33.

Talkative patients.

Friedman JH.

R I Med J (2013). 2017 Nov 1;100(11):8-9.

PMID:
29088566
34.

What is a disease?

Friedman JH.

R I Med J (2013). 2017 Oct 2;100(10):8-9.

PMID:
28968611
35.

The woman who could spell backwards.

Friedman JH.

R I Med J (2013). 2017 Sep 1;100(9):8. No abstract available.

PMID:
28873474
36.

Doctors falling down on the job.

Friedman JH.

R I Med J (2013). 2017 Aug 1;100(8):7-8. No abstract available.

PMID:
28759891
37.

Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!

Friedman JH.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S6-S9. doi: 10.1016/j.parkreldis.2017.07.013. Epub 2017 Jul 18. Review.

PMID:
28756177
38.

Superaging, the new phrenology, and the gluten-free diet for the brain.

Friedman JH.

R I Med J (2013). 2017 Jul 5;100(7):8-9. No abstract available.

PMID:
28686232
39.

A Retrospective Study of Pimavanserin Use in a Movement Disorders Clinic.

Friedman JH.

Clin Neuropharmacol. 2017 Jul/Aug;40(4):157-159. doi: 10.1097/WNF.0000000000000219.

PMID:
28622212
40.

Drug-induced parkinsonism.

Friedman JH.

Mov Disord. 2017 Jul;32(7):1111. doi: 10.1002/mds.27050. Epub 2017 Jun 14. No abstract available.

PMID:
28612949
41.

Crimes against humanity.

Friedman JH.

R I Med J (2013). 2017 Jun 1;100(6):8-9. No abstract available.

PMID:
28564660
42.

Nonmotor Symptoms in Parkinson's Disease.

Akbar U, D'Abreu A, Friedman JH.

Semin Neurol. 2017 Apr;37(2):158-166. doi: 10.1055/s-0037-1602424. Epub 2017 May 16. Review.

PMID:
28511256
43.

Malingering?

Friedman JH.

R I Med J (2013). 2017 May 1;100(5):8-9. No abstract available.

PMID:
28459913
44.

Voting Aliens, Donald Trump and Me.

Friedman JH.

R I Med J (2013). 2017 Apr 3;100(4):7-8. No abstract available.

PMID:
28375412
45.

Political Correctness.

Friedman JH.

R I Med J (2013). 2017 Mar 1;100(3):8-9. No abstract available.

PMID:
28246650
46.

White Coats.

Friedman JH.

R I Med J (2013). 2017 Feb 1;100(2):9-10. No abstract available.

PMID:
28146592
47.

Editorial and introduction: Behavioral aspects of Parkinson's disease.

Friedman JH, Bhidayasiri R, Truong DD.

J Neurol Sci. 2017 Mar 15;374:1-2. doi: 10.1016/j.jns.2017.01.006. Epub 2017 Jan 4. No abstract available.

PMID:
28087061
48.

Misperceptions and Parkinson's disease.

Friedman JH.

J Neurol Sci. 2017 Mar 15;374:42-46. doi: 10.1016/j.jns.2016.12.059. Epub 2017 Jan 4. Review.

PMID:
28073433
49.

Centennial Thoughts.

Friedman JH.

R I Med J (2013). 2017 Jan 6;100(1):5-6. No abstract available.

PMID:
28060962
50.

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators.

Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2.

Supplemental Content

Loading ...
Support Center